American Journal of Epidemiology Vol. 154, No. 7 : 635-641
Copyright © 2001 by The Johns Hopkins University School of Hygiene and Public Health
ORIGINAL CONTRIBUTIONS |
Diabetes Mellitus and Risk of Alzheimer's Disease and Dementia with Stroke in a Multiethnic Cohort
1 Taub Institute for Research of Alzheimer's Disease and the Aging Brain, Columbia University, New York, NY.
2 Division of General Medicine, Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY.
3 Division of Biostatistics, Joseph P. Mailman School of Public Health, Columbia University, New York, NY.
4 Gertrude H. Sergievsky Center, Columbia University, New York, NY.
5 Department of Psychiatry, College of Physicians and Surgeons, Columbia University, New York, NY.
6 Division of Epidemiology, Joseph P. Mailman School of Public Health, Columbia University, New York, NY.
7 Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, NY.
Research on the relation between diabetes mellitus and dementia has produced conflicting results, and the relation has not been investigated among Blacks and Hispanics. In this study, Cox proportional hazards models were used to analyze longitudinal data from 1,262 elderly subjects without dementia at baseline (1991–1996) who were followed for an average of 4.3 years between 1992 and 1997. Outcomes were incident Alzheimer's disease and dementia associated with stroke. The prevalence of diabetes was 20% at baseline. The adjusted relative risk of Alzheimer's disease among persons with diabetes as compared with those without diabetes was 1.3 (95% confidence interval (CI): 0.8, 1.9). The adjusted relative risk for the composite outcome of Alzheimer's disease and cognitive impairment without dementia (without stroke) in subjects with diabetes was 1.6 (95% CI: 1.2, 2.1). The adjusted relative risk of stroke-associated dementia in persons with diabetes was 3.4 (95% CI: 1.7, 6.9). Among Blacks and Hispanics, approximately one third of the risk of stroke-associated dementia was attributable to diabetes (33% (95% CI: 31, 36) and 36% (95% CI: 33, 37), respectively), as compared with 17% (95% CI: 13, 22) among Whites. The finding of an association between diabetes and the composite outcome of Alzheimer's disease and cognitive impairment without dementia (without stroke) is consistent with prior reports of a modest relation between diabetes and Alzheimer's disease.
Alzheimer disease; dementia; diabetes mellitus; survival analysis
Abbreviations: CI, confidence interval; NINCDS-ADRDA, National Institute of Neurological and Communicative Disorders and Stroke–Alzheimer's Disease and Related Disorders Association; NINDS-AIREN, National Institute of Neurological Disorders and Stroke–Association Internationale pour la Recherche et l'Enseignement en Neurosciences.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  S. M. Albert, J. Bear-Lehman, and A. Burkhardt Lifestyle-Adjusted Function: Variation Beyond BADL and IADL Competencies Gerontologist, December 1, 2009; 49(6): 767 - 777. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A Alonso, T H Mosley Jr, R F Gottesman, D Catellier, A R Sharrett, and J Coresh Risk of dementia hospitalisation associated with cardiovascular risk factors in midlife and older age: the Atherosclerosis Risk in Communities (ARIC) study J. Neurol. Neurosurg. Psychiatry, November 1, 2009; 80(11): 1194 - 1201. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Grossman Should We Treat Prehypertension in Diabetes?: What are the cons? Diabetes Care, November 1, 2009; 32(suppl_2): S280 - S283. [Full Text] [PDF]
|
|
|
|
|
|
J. S. Saczynski, S. Siggurdsson, P. V. Jonsson, G. Eiriksdottir, E. Olafsdottir, O. Kjartansson, T. B. Harris, M. A. van Buchem, V. Gudnason, and L. J. Launer Glycemic Status and Brain Injury in Older Individuals: The Age Gene/Environment Susceptibility-Reykjavik Study Diabetes Care, September 1, 2009; 32(9): 1608 - 1613. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. P. Helzner, J. A. Luchsinger, N. Scarmeas, S. Cosentino, A. M. Brickman, M. M. Glymour, and Y. Stern Contribution of Vascular Risk Factors to the Progression in Alzheimer Disease Arch Neurol, March 1, 2009; 66(3): 343 - 348. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Launer Diabetes: Vascular or Neurodegenerative: An Epidemiologic Perspective Stroke, March 1, 2009; 40(3_suppl_1): S53 - S55. [Full Text] [PDF]
|
|
|
|
 |
|
 B. Kuczynski, W. Jagust, H. C. Chui, and B. Reed An inverse association of cardiovascular risk and frontal lobe glucose metabolism Neurology, February 24, 2009; 72(8): 738 - 743. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Cukierman-Yaffe, H. C. Gerstein, J. D. Williamson, R. M. Lazar, L. Lovato, M. E. Miller, L. H. Coker, A. Murray, M. D. Sullivan, S. M. Marcovina, et al. Relationship Between Baseline Glycemic Control and Cognitive Function in Individuals With Type 2 Diabetes and Other Cardiovascular Risk Factors: The Action to Control Cardiovascular Risk in Diabetes-Memory in Diabetes (ACCORD-MIND) trial Diabetes Care, February 1, 2009; 32(2): 221 - 226. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Viswanathan, W. A. Rocca, and C. Tzourio Vascular risk factors and dementia: How to move forward? Neurology, January 27, 2009; 72(4): 368 - 374. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Xu, C. Qiu, M. Gatz, N. L. Pedersen, B. Johansson, and L. Fratiglioni Mid- and Late-Life Diabetes in Relation to the Risk of Dementia: A Population-Based Twin Study Diabetes, January 1, 2009; 58(1): 71 - 77. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. S. Saczynski, M. K. Jonsdottir, M. E. Garcia, P. V. Jonsson, R. Peila, G. Eiriksdottir, E. Olafsdottir, T. B. Harris, V. Gudnason, and L. J. Launer Cognitive Impairment: An Increasingly Important Complication of Type 2 Diabetes: The Age, Gene/Environment Susceptibility-Reykjavik Study Am. J. Epidemiol., November 15, 2008; 168(10): 1132 - 1139. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Coley, S. Andrieu, V. Gardette, S. Gillette-Guyonnet, C. Sanz, B. Vellas, and A. Grand Dementia Prevention: Methodological Explanations for Inconsistent Results Epidemiol. Rev., November 1, 2008; 30(1): 35 - 66. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Whitmer, D. R. Gustafson, E. Barrett-Connor, M. N. Haan, E. P. Gunderson, and K. Yaffe Central obesity and increased risk of dementia more than three decades later Neurology, September 30, 2008; 71(14): 1057 - 1064. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Sander, K. Sander, and H. Poppert Review: Stroke in type 2 diabetes The British Journal of Diabetes & Vascular Disease, September 1, 2008; 8(5): 222 - 229. [Abstract] [PDF]
|
|
|
|
 |
|
 C. T. Kodl and E. R. Seaquist Cognitive Dysfunction and Diabetes Mellitus Endocr. Rev., June 1, 2008; 29(4): 494 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Brodbeck, M. E. Balestra, A. M. Saunders, A. D. Roses, R. W. Mahley, and Y. Huang Rosiglitazone increases dendritic spine density and rescues spine loss caused by apolipoprotein E4 in primary cortical neurons PNAS, January 29, 2008; 105(4): 1343 - 1346. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Planel, Y. Tatebayashi, T. Miyasaka, L. Liu, L. Wang, M. Herman, W. H. Yu, J. A. Luchsinger, B. Wadzinski, K. E. Duff, et al. Insulin Dysfunction Induces In Vivo Tau Hyperphosphorylation through Distinct Mechanisms J. Neurosci., December 12, 2007; 27(50): 13635 - 13648. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. M. Mielke, P. B. Rosenberg, J. Tschanz, L. Cook, C. Corcoran, K. M. Hayden, M. Norton, P. V. Rabins, R. C. Green, K. A. Welsh-Bohmer, et al. Vascular factors predict rate of progression in Alzheimer disease Neurology, November 6, 2007; 69(19): 1850 - 1858. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ramirez, J. A. Teresi, D. Holmes, V. Martinez, and R. Lantigua Prevalence Estimates and Health-Related Correlates of Cognitive Impairment From a Probability Sample of Community-Residing Latino Elders J Aging Health, August 1, 2007; 19(4): 559 - 574. [Abstract] [PDF]
|
|
|
|
|
|
J. A. Luchsinger, C. Reitz, B. Patel, M.-X. Tang, J. J. Manly, and R. Mayeux Relation of Diabetes to Mild Cognitive Impairment Arch Neurol, April 1, 2007; 64(4): 570 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Arvanitakis, J. A. Schneider, R. S. Wilson, Y. Li, S. E. Arnold, Z. Wang, and D. A. Bennett Diabetes is related to cerebral infarction but not to AD pathology in older persons Neurology, December 12, 2006; 67(11): 1960 - 1965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. L. Xiong, B. L. Plassman, M. J. Helms, and D. C. Steffens Vascular risk factors and cognitive decline among elderly male twins. Neurology, November 14, 2006; 67(9): 1586 - 1591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Akomolafe, A. Beiser, J. B. Meigs, R. Au, R. C. Green, L. A. Farrer, P. A. Wolf, and S. Seshadri Diabetes Mellitus and Risk of Developing Alzheimer Disease: Results From the Framingham Study Arch Neurol, November 1, 2006; 63(11): 1551 - 1555. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Ortiz, L. J. Fitten, J. L. Cummings, S. Hwang, and M. Fonseca Neuropsychiatric and behavioral symptoms in a community sample of Hispanics with Alzheimer's disease. American Journal of Alzheimer's Disease and Other Dementias, August 1, 2006; 21(4): 263 - 273. [Abstract] [PDF]
|
|
|
|
 |
|
 S. M. Albert, J. Bear-Lehman, A. Burkhardt, B. Merete-Roa, R. Noboa-Lemonier, and J. Teresi Variation in sources of clinician-rated and self-rated instrumental activities of daily living disability. J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2006; 61(8): 826 - 831. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bhargava, M. F. Weiner, L. S. Hynan, R. Diaz-Arrastia, and A. M. Lipton Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. J Geriatr Psychiatry Neurol, June 1, 2006; 19(2): 78 - 82. [Abstract] [PDF]
|
|
|
|
|
|
T. Sato, N. Shimogaito, X. Wu, S. Kikuchi, S.-i. Yamagishi, and M. Takeuchi Toxic Advanced Glycation End Products (TAGE) Theory in Alzheimer's Disease American Journal of Alzheimer's Disease and Other Dementias, May 1, 2006; 21(3): 197 - 208. [Abstract] [PDF]
|
|
|
|
|
|
J. A. Luchsinger, C. Reitz, L. S. Honig, M. X. Tang, S. Shea, and R. Mayeux Aggregation of vascular risk factors and risk of incident Alzheimer disease Neurology, August 23, 2005; 65(4): 545 - 551. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. A Whitmer, E. P Gunderson, E. Barrett-Connor, C. P Quesenberry Jr, and K. Yaffe Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study BMJ, June 11, 2005; 330(7504): 1360. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Cole, A. Grudzien, I. O. Manhart, B. L. Kelly, H. Oakley, and R. Vassar Statins Cause Intracellular Accumulation of Amyloid Precursor Protein, {beta}-Secretase-cleaved Fragments, and Amyloid {beta}-Peptide via an Isoprenoid-dependent Mechanism J. Biol. Chem., May 13, 2005; 280(19): 18755 - 18770. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. S. Honig, W. Kukull, and R. Mayeux Atherosclerosis and AD: Analysis of data from the US National Alzheimer's Coordinating Center Neurology, February 8, 2005; 64(3): 494 - 500. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. A. Whitmer, S. Sidney, J. Selby, S. C. Johnston, and K. Yaffe Midlife cardiovascular risk factors and risk of dementia in late life Neurology, January 25, 2005; 64(2): 277 - 281. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Schnaider Beeri, U. Goldbourt, J. M. Silverman, S. Noy, J. Schmeidler, R. Ravona-Springer, A. Sverdlick, and M. Davidson Diabetes mellitus in midlife and the risk of dementia three decades later Neurology, November 23, 2004; 63(10): 1902 - 1907. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. L. Xu, C. X. Qiu, A. Wahlin, B. Winblad, and L. Fratiglioni Diabetes mellitus and risk of dementia in the Kungsholmen project: A 6-year follow-up study Neurology, October 12, 2004; 63(7): 1181 - 1186. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Luchsinger, M.-X. Tang, S. Shea, and R. Mayeux Hyperinsulinemia and risk of Alzheimer disease Neurology, October 12, 2004; 63(7): 1187 - 1192. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Yaffe, T. Blackwell, A. M. Kanaya, N. Davidowitz, E. Barrett-Connor, and K. Krueger Diabetes, impaired fasting glucose, and development of cognitive impairment in older women Neurology, August 24, 2004; 63(4): 658 - 663. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Arvanitakis, R. S. Wilson, J. L. Bienias, D. A. Evans, and D. A. Bennett Diabetes Mellitus and Risk of Alzheimer Disease and Decline in Cognitive Function Arch Neurol, May 1, 2004; 61(5): 661 - 666. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Farris, S. Mansourian, M. A. Leissring, E. A. Eckman, L. Bertram, C. B. Eckman, R. E. Tanzi, and D. J. Selkoe Partial Loss-of-Function Mutations in Insulin-Degrading Enzyme that Induce Diabetes also Impair Degradation of Amyloid {beta}-Protein Am. J. Pathol., April 1, 2004; 164(4): 1425 - 1434. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Logroscino, J. H. Kang, and F. Grodstein Prospective study of type 2 diabetes and cognitive decline in women aged 70-81 years BMJ, March 6, 2004; 328(7439): 548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. C. Johnston, E. S. O'Meara, T. A. Manolio, D. Lefkowitz, D. H. O'Leary, S. Goldstein, M. C. Carlson, L. P. Fried, and W. T. Longstreth Jr. Cognitive Impairment and Decline Are Associated with Carotid Artery Disease in Patients without Clinically Evident Cerebrovascular Disease Ann Intern Med, February 17, 2004; 140(4): 237 - 247. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Janson, T. Laedtke, J. E. Parisi, P. O'Brien, R. C. Petersen, and P. C. Butler Increased Risk of Type 2 Diabetes in Alzheimer Disease Diabetes, February 1, 2004; 53(2): 474 - 481. [Abstract] [Full Text]
|
|
|
|
|
|
L. S. Honig, M.-X. Tang, S. Albert, R. Costa, J. Luchsinger, J. Manly, Y. Stern, and R. Mayeux Stroke and the Risk of Alzheimer Disease Arch Neurol, December 1, 2003; 60(12): 1707 - 1712. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Ho, F. Paultre, and L. Mosca Is Diabetes Mellitus a Cardiovascular Disease Risk Equivalent for Fatal Stroke in Women?: Data From the Women's Pooling Project Stroke, December 1, 2003; 34(12): 2812 - 2816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. E. Roher, C. Esh, T. A. Kokjohn, W. Kalback, D. C. Luehrs, J. D. Seward, L. I. Sue, and T. G. Beach Circle of Willis Atherosclerosis Is a Risk Factor for Sporadic Alzheimer's Disease Arterioscler Thromb Vasc Biol, November 1, 2003; 23(11): 2055 - 2062. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. F. Luscher, M. A. Creager, J. A. Beckman, and F. Cosentino Diabetes and Vascular Disease: Pathophysiology, Clinical Consequences, and Medical Therapy: Part II Circulation, September 30, 2003; 108(13): 1655 - 1661. [Full Text] [PDF]
|
|
|
|
 |
|
 E. W. Gregg and A. Brown Cognitive and Physical Disabilities and Aging-Related Complications of Diabetes Clin. Diabetes, July 1, 2003; 21(3): 113 - 118. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. WHALLEY Brain ageing and dementia: what makes the difference? The British Journal of Psychiatry, November 1, 2002; 181(5): 369 - 371. [Full Text] [PDF]
|
|
|
|
|
|
E. W Gregg, M. M Engelgau, and V. Narayan Complications of diabetes in elderly people BMJ, October 26, 2002; 325(7370): 916 - 917. [Full Text] [PDF]
|
|
|
|
|
|
D Liolitsa, J Powell, and S Lovestone Genetic variability in the insulin signalling pathway may contribute to the risk of late onset Alzheimer's disease J. Neurol. Neurosurg. Psychiatry, September 1, 2002; 73(3): 261 - 266. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. M. Greenberg Cerebral amyloid angiopathy and dementia: Two amyloids are worse than one Neurology, June 11, 2002; 58(11): 1587 - 1588. [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Beckman, M. A. Creager, and P. Libby Diabetes and Atherosclerosis: Epidemiology, Pathophysiology, and Management JAMA, May 15, 2002; 287(19): 2570 - 2581. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. B. Posner, M.-X. Tang, J. Luchsinger, R. Lantigua, Y. Stern, and R. Mayeux The relationship of hypertension in the elderly to AD, vascular dementia, and cognitive function Neurology, April 23, 2000; 58(8): 1175 - 1181. [Abstract] [Full Text] [PDF]
|
|